SuperGen, Inc. (NASDAQ: SUPG) has announced the voluntary dismissal of the securities class action against the pharmaceutical company. The suit, originally filed in April in the U.S. District Court for the Northern District of California, alleged that the company sold shares while failing to disclose material information about one of its drugs.
Search
Follow by RSS
Topics
Archives
Disclaimer
This blog is for informational purposes only. In other words, it does not constitute legal advice and is not intended to create an attorney-client relationship. Online readers should not act upon any information presented on this blog without seeking professional legal counsel. Finally, the posts on this blog represent the personal views of Lyle Roberts, not the views of his law firm or clients.
The author apologizes for any factual errors in this blog. Although he will act quickly to correct errors pointed out to him, he declines to take responsibility for the mischief that may result in the interim.
The 10b-5 Daily · News and events related to securities class action litigation. Containing all facts, with particularity, and an occasional dose of commentary.
The 10b-5 Daily 